Glaucoma News

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, I. Paul Singh, MD, discusses phase 3 data on the iDose TR implant from Glaukos.

VVN539 ophthalmic solution met its primary endpoints for the treatment of primary open-angle glaucoma or ocular hypertension in a phase 2 study, according to a press release from VivaVision Biotech.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Nathan M. Radcliffe, MD, explains why endoscopic cyclophotocoagulation is a versatile MIGS procedure.

Canaloplasty and trabeculotomy performed with the Omni surgical system provided patients with glaucoma with sustained IOP control over 2 years, according to a study published in Clinical Ophthalmology.

In a 2020 position statement on microinvasive glaucoma surgery, the American Glaucoma Society said:

The volume of minimally invasive glaucoma surgery has increased significantly in recent years, providing an alternative to traditional glaucoma surgeries.

I was honored to give the Stephen A. Obstbaum, MD, Lecture at the 2022 American Society of Cataract and Refractive Surgery meeting and the Ridley Medal Lecture at the 2023 Snowmass Retina & Eye meeting.

Generations of ophthalmologists have treated primary open-angle glaucoma largely the same way, instituting and escalating the dosages of drops.

NEW ORLEANS— In this Healio Video Perspective from the ARVO meeting, Kaushal Solanki discusses the EyeArt AI eye screening system, which was cleared by the FDA for diabetic retinopathy detection in 2020.

I think of my clinic as a triad, encompassing three conditions: dry eye disease, glaucoma and cataract.